181 related articles for article (PubMed ID: 2468942)
1. Ketanserin: systemic and regional hemodynamic characterization of its serotonergic and alpha-adrenergic receptor blocking effects in the pithed SHR.
Scalbert E; Richer C; Giudicelli JF
J Cardiovasc Pharmacol; 1989 Jan; 13(1):94-104. PubMed ID: 2468942
[TBL] [Abstract][Full Text] [Related]
2. Systemic and regional hemodynamic characterization of alpha-1 and alpha-2 adrenoceptor agonists in pithed rats.
Richer C; Lefevre-Borg F; Lechaire J; Gomeni C; Gomeni R; Giudicelli JF; Cavero I
J Pharmacol Exp Ther; 1987 Mar; 240(3):944-53. PubMed ID: 2882016
[TBL] [Abstract][Full Text] [Related]
3. [Atrial natriuretic factor. Systemic and regional hemodynamic profile and interaction with the alpha-adrenergic system in pithed SHR rats].
Richer C; Doussau MP; Giudicelli JF
Arch Mal Coeur Vaiss; 1987 Jun; 80(6):970-5. PubMed ID: 3116998
[TBL] [Abstract][Full Text] [Related]
4. [Nicardipine: experimental antihypertensive action and interactions with the alpha-adrenergic sympathetic system].
Richer C; Lefevre-Borg F; Cadilhac M; Cavero I; Giudicelli JF
J Pharmacol; 1985; 16(1):45-58. PubMed ID: 2860269
[TBL] [Abstract][Full Text] [Related]
5. Ketanserin: systemic and regional hemodynamics in spontaneously hypertensive rats. Role of alpha 1-adrenoceptor blockade.
Richer C; Scalbert E; Doussau MP; Duhaze P; Giudicelli JF
Eur J Pharmacol; 1987 Jul; 139(1):31-42. PubMed ID: 2888664
[TBL] [Abstract][Full Text] [Related]
6. Ketanserin-induced baroreflex enhancement in spontaneously hypertensive rats depends on central 5-HT(2A) receptors.
Shen FM; Wang J; Ni CR; Yu JG; Wang WZ; Su DF
Clin Exp Pharmacol Physiol; 2007 Aug; 34(8):702-7. PubMed ID: 17600544
[TBL] [Abstract][Full Text] [Related]
7. Existence of spare alpha 1-adrenoreceptors, but not alpha 2-adrenoreceptors, for respective vasopressor effects of cirazoline and B-HT 933 in the pithed rat.
Ruffolo RR; Yaden EL
J Cardiovasc Pharmacol; 1984; 6(6):1011-9. PubMed ID: 6084756
[TBL] [Abstract][Full Text] [Related]
8. An investigation of the effects of intravenous injection of the 5-hydroxytryptamine 2 receptor antagonists ketanserin and LY 53857 on blood pressure in anesthetized spontaneously hypertensive rats.
Docherty JR
J Pharmacol Exp Ther; 1989 Feb; 248(2):736-40. PubMed ID: 2537414
[TBL] [Abstract][Full Text] [Related]
9. Differences in the acute and chronic antihypertensive mechanism of action of ketanserin in spontaneously hypertensive rats.
Balasubramaniam G; Lee HS; Mah SC
J Pharmacol Exp Ther; 1993 Jan; 264(1):129-34. PubMed ID: 8093720
[TBL] [Abstract][Full Text] [Related]
10. Effects of antagonists of 5-hydroxytryptamine on blood pressure in the anesthetised spontaneously hypertensive rat.
Docherty JR; Warnock P
J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S59-61. PubMed ID: 2446073
[TBL] [Abstract][Full Text] [Related]
11. Potential vascular alpha1-adrenoceptor blocking properties of an array of 5-HT receptor ligands in the rat.
Centurión D; Mehotra S; Sánchez-López A; Gupta S; MaassenVanDenBrink A; Villalón CM
Eur J Pharmacol; 2006 Mar; 535(1-3):234-42. PubMed ID: 16545797
[TBL] [Abstract][Full Text] [Related]
12. Comparison between ketanserin and LY 53857 on vascular and cardiac 5-HT2 and alpha 1-adrenergic receptors in the pithed rat.
Dabiré H; Chaouche-Teyara K; Cherqui C; Fournier B; Schmitt H
Arch Int Pharmacodyn Ther; 1990; 306():57-64. PubMed ID: 1981667
[TBL] [Abstract][Full Text] [Related]
13. Functional and biochemical evidence for the lack of cardiac presynaptic alpha-2 adrenoceptor stimulant properties of cirazoline (LD 3098), a potent alpha-1 adrenoceptor agonist in dogs and rats.
Cavero I; Lefèvre-Borg F; Roach AG; Gomeni R; Scatton B
J Pharmacol Exp Ther; 1982 Oct; 223(1):241-50. PubMed ID: 6126583
[TBL] [Abstract][Full Text] [Related]
14. Differences in the chronic hypotensive mechanism of action of ketanserin in spontaneously hypertensive and Wistar-Kyoto rats.
Balasubramaniam G; Lee HS; Mah SC
J Hypertens; 1994 Jan; 12(1):7-14. PubMed ID: 8157947
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular profile and hypotensive mechanism of ketanserin in the rabbit.
Bolt GR; Saxena PR
Hypertension; 1985; 7(4):499-506. PubMed ID: 2861161
[TBL] [Abstract][Full Text] [Related]
16. Ketanserin: a possible tool for studying the role of serotonin in hypertension.
Woittiez AJ; Wenting GJ; Man in't Veld AJ; Boomsma F; Schalekamp MA
J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S130-6. PubMed ID: 2412035
[TBL] [Abstract][Full Text] [Related]
17. Local hemodynamic effects of serotonin and ketanserin in healthy subjects: studies in the forearm.
Blauw GJ; van Brummelen P; Bruning T; van Zwieten PA
J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S41-3. PubMed ID: 2459513
[TBL] [Abstract][Full Text] [Related]
18. Effects of alpha-adrenoceptor agonists on cardiac output and its regional distribution in the pithed rat.
Hiley CR; Thomas GR
Br J Pharmacol; 1987 Jan; 90(1):61-70. PubMed ID: 2880628
[TBL] [Abstract][Full Text] [Related]
19. Systemic and regional haemodynamic interactions between K+ channel openers and the sympathetic nervous system in the pithed SHR.
Richer C; Mulder P; Doussau MP; Gautier P; Giudicelli JF
Br J Pharmacol; 1990 Jul; 100(3):557-63. PubMed ID: 2390680
[TBL] [Abstract][Full Text] [Related]
20. Regional hemodynamic effects of purinergic P2 receptor subtype agonists in rats.
Cox BF; Smits GJ
J Pharmacol Exp Ther; 1996 Jun; 277(3):1492-500. PubMed ID: 8667215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
